Treatment of Metabolic Syndrome in Children.

Adolescent Child Female Humans Male Metabolic Syndrome / therapy Pediatric Obesity / therapy Risk Factors
Children Fatty liver disease Hypertension Insulin resistance Metabolic syndrome

Journal

Hormone research in paediatrics
ISSN: 1663-2826
Titre abrégé: Horm Res Paediatr
Pays: Switzerland
ID NLM: 101525157

Informations de publication

Date de publication:
2020
Historique:
received: 29 02 2020
accepted: 18 08 2020
pubmed: 6 10 2020
medline: 14 8 2021
entrez: 5 10 2020
Statut: ppublish

Résumé

Although metabolic syndrome (MetS) in children and adolescents is a frequently discussed topic in the literature, uniform guidelines on its definition and treatment are still lacking. Insulin resistance, central obesity, dyslipidaemia, and hypertension are commonly considered the main components of MetS. The first recommended approach to all these pathological conditions in children and adolescents is lifestyle intervention (diet and physical exercise); however, in some selected cases, a pharmacological or surgical treatment might prove useful for the prevention of metabolic and cardiovascular complications. The aim of this review is to present the more recent evidence about the treatment of the major components of MetS in children and adolescents, focussing on the current recommendations concerning lifestyle changes, available drugs, and bariatric surgery.

Identifiants

DOI: 10.1159/000510941 PMID: 33017828
pubmed: 33017828
pii: 000510941
doi: 10.1159/000510941
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

215-225

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Veronica Maria Tagi (VM)

Department of Paediatrics, University of Chieti, Chieti, Italy.

Sona Samvelyan (S)

Department of Paediatrics, University of Chieti, Chieti, Italy.

Francesco Chiarelli (F)

Department of Paediatrics, University of Chieti, Chieti, Italy, chiarelli@unich.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adolescent › Treatment of Metabolic Syndrome in Children.
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Treatment of Metabolic Syndrome in Children.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Treatment of Metabolic Syndrome in Children.
questionsmedicales.fr › Maladies métaboliques et nutritionnelles › Maladies métaboliques › Syndrome métabolique X › Treatment of Metabolic Syndrome in Children.
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Obésité › Obésité pédiatrique › Treatment of Metabolic Syndrome in Children.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Treatment of Metabolic Syndrome in Children.